Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of ...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...

Laura Hillier suffered from acute myeloid leukemia, a cancer of the blood for which "the treatment is so severe, the chemo is so intense," her mother said of the standard chemothe ...

Updated cervical cancer screening guidance from the American College of Obstetricians and Gynecologists endorsed at-home ...

NEW YORK – Create Medicines has started clinically testing an in vivo CAR therapy that comprises a cancer-killing medley of T, NK, and myeloid cells.

Daiichi Sankyo’s full-year report was originally scheduled for April 27 but has now been pushed back to May 11. That same day ...

UAE scientists have used artificial intelligence (AI) to develop a potential cancer treatment in under a year, marking a ...

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

Explore how BTK resistance drives poor outcomes in relapsed mantle cell lymphoma and why ZUMA-2 CAR T therapy emerges as a ...

Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Telix has delivered a string of radiopharmaceuticals greatest hits with more to come but there have also been some misses ...